{
Severin Schwan

People

}
credit suisse scandal reveals extensive surveillance operations under ceo tidjane thiam
Tidjane Thiam, former CEO of Credit Suisse, allegedly ordered the surveillance of his girlfriend's ex-husband shortly after taking office in 2016, a plan that remained hidden until the 2019 exposure of another spying incident. The ongoing trial in Washington, where the ex-husband claims $15 million in damages, reveals a troubling culture of espionage within the bank, suggesting that such practices may have been prevalent even before Thiam's tenure. UBS, as the legal successor, now faces the fallout from these revelations, tarnishing its reputation in the critical U.S. financial market.
insideparadeplatz.ch
Microsoft Corporation Hoffmann-La Roche AG Credit Suisse Anlagestiftung UBS AG USA Thomas Gottstein Pierre-Olivier Bouée Tidjane Thiam Severin Schwan Urs Rohner Iqbal Khan Show more
TradFi, News Article
07:59 06.11.2024
gottstein's refusal to merge accelerates downfall of credit suisse
Thomas Gottstein's refusal to support a merger between UBS and Credit Suisse (CS) in 2020 marked the beginning of CS's decline, as he believed he could independently steer the bank back to stability. Despite significant losses from the Greensill and Archegos scandals, he remained CEO until 2022, while Urs Rohner, the Chairman, failed to hold him accountable. Ultimately, UBS acquired CS for a mere $3 billion amid the fallout from the Silicon Valley banking crisis, highlighting the missteps of both Gottstein and Rohner in navigating the bank's challenges.
insideparadeplatz.ch
United States Dollar UBS AG Hoffmann-La Roche AG CS Baumann CHE Thomas Gottstein Axel Weber Sergio Ermotti Ueli Maurer Severin Schwan Show more
TradFi, News Article
07:59 29.10.2024
ubs avoids merger with credit suisse in 2020 amid liquidity concerns
Credit Suisse (CS) faced severe liquidity issues during the Covid crisis, being the only global systemically important bank unable to meet its requirements, which led to failed merger talks with UBS in 2020. UBS later acquired CS in 2023, benefiting from the latter's weakened state and government guarantees, avoiding the risks and costs associated with a merger three years earlier. UBS's management had long viewed CS as doomed, particularly after its 2015 strategy under Tidjane Thiam, which was seen as a dead end.
Neue Zürcher Zeitung
Swiss Franc Prudential Ltd. UBS AG Hoffmann-La Roche AG Credit Suisse Anlagestiftung CHE Thomas Gottstein Tidjane Thiam Ralph Hamers Sergio Ermotti Severin Schwan Show more
TradFi, Market Report
05:30 29.10.2024
switzerland's top ceos earn record salaries attracting global talent
Switzerland stands out as the highest-paying country for CEOs, with compensation packages that far exceed those in the USA and UK. The top earners, Severin Schwan of Roche and Juan Carlos Torres Carretero of Avolta, each earn 5.7 million francs, attracting corporate leaders from across Europe.
cash.ch
Swiss Franc AVOLTA N Hoffmann-La Roche AG CHE Severin Schwan Juan Carlos Torres Carretero
Finance & Economy, Market Report
08:00 26.10.2024
Roche's leadership under Schwan faces scrutiny amid research setbacks and stock decline
Severin Schwan's leadership at Roche faces scrutiny amid declining stock prices and research setbacks, contrasting with competitors like Novo Nordisk and Eli Lilly. While Schwan's cautious approach has fostered stability, analysts question the pipeline's potential for future blockbuster drugs, leaving Roche's growth prospects uncertain.
Neue Zürcher Zeitung
Swiss Franc Eli Lilly and Company Hoffmann-La Roche AG Novo Nordisk A/S Credit Suisse Anlagestiftung Flatiron Baseball LLC CHE DEU Alain Berset Severin Schwan Ignazio Cassis Thomas Schinecker Guy Parmelin Show more
Healthcare, Market Report
09:00 05.10.2024
Roche's new strategy focuses on promising drugs and streamlined research efforts
Roche, under CEO Thomas Schinecker, is streamlining its operations by focusing on five key therapeutic areas: neurology, oncology, eye diseases, immunology, and cardiovascular/metabolic diseases. The company is prioritizing promising drugs like CT-388, an injection aimed at significant weight loss, while addressing internal inefficiencies and aiming for faster clinical trials. Despite setbacks, Roche is determined to enhance its drug pipeline and maintain competitive growth in the pharmaceutical market.
watson.ch
Hoffmann-La Roche AG CHE Thomas Schinecker Severin Schwan
Healthcare, News Article
09:00 02.10.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Central Bank Actions Banking Regulations Corporate Responsibility & ESG Decentralized Finance (DeFi) Innovations Tokenomics and Crypto Economics Mergers & Acquisitions Cryptocurrency & Blockchain Regulations Cryptocurrency Developments Blockchain Technology Adoption Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Emerging Startups Cryptocurrency Regulations Inflation Rates & CPI Data SEC & Financial Compliance Banking & Investment Regulations
Countries:
USA CHE GBR DEU ARE HKG AUS JPN CHN IND SGP DNK CAN NGA FIN COL AUT VGB LIE TUR
Companies:
Credit Suisse Real Estate Fund Siat BlackRock, Inc. Coinbase Global, Inc. Solana USD Ethereum USD Ripples USD Apple Inc. Tesla, Inc. Fidelity Contrafund Cardano USD NVIDIA Corporation Grayscale Litecoin Trust Chainlink USD Tether USDt CNY Google Inc. Amazon.com, Inc. MicroStrategy Inc Franklin Templeton - Franklin M End Federal Reserve USD MicroStrategy Incorporated
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Indian Rupee Canadian Dollar Mozambican Metical British Pound Sterling Norwegian Krone Mongolian Tögrög Colombian Peso Singapore Dollar
People:
Donald Trump Ali Martinez Elon Musk Karin Keller-Sutter Jerome Powell Ueli Maurer Michael J. Saylor Thomas Jordan Gary Gensler Colm Kelleher Alan Santana Paul Atkins Joe Rogan Martin Schlegel Isabelle Chassot Mario Nawfal Paolo Ardoino Sergio Ermotti Dana White Joe Biden

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.